1. Optimization of dose and route of administration of the P‐glycoprotein inhibitor, valspodar (PSC‐833) and the P‐glycoprotein and breast cancer resistance protein dual‐inhibitor, elacridar (GF120918) as dual infusion in rats. Issue 2 (4th March 2021) Authors: Rowbottom, Christopher; Pietrasiewicz, Alicia; Tuczewycz, Taras; Grater, Richard; Qiu, Daniel; Kapadnis, Sudarshan; Trapa, Patrick Journal: Pharmacology research & perspectives Issue: Volume 9:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗